ACADIA Pharmaceuticals
ACAD
#3888
Rank
S$4.36 B
Marketcap
S$25.51
Share price
0.30%
Change (1 day)
-7.39%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total debt

Total debt on the balance sheet as of June 2026 : S$94.45 Million

According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is S$94.45 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31S$67 M-5.2%
2024-12-31S$70.67 M-6.45%
2023-12-31S$75.55 M-9.1%
2022-12-31S$83.11 M-4.58%
2021-12-31S$87.1 M32.89%
2020-12-31S$65.54 M396.37%
2019-12-31S$13.2 M
2018-12-31N/A
2011-12-31S$0.04 M-70.75%
2010-12-31S$0.14 M-78.2%
2009-12-31S$0.65 M-62.9%
2008-12-31S$1.75 M-42.95%
2007-12-31S$3.07 M-15.68%
2006-12-31S$3.64 M22.74%
2005-12-31S$2.96 M-28.11%
2004-12-31S$4.12 M-50.08%
2003-12-31S$8.26 M-25.94%
2002-12-31S$11.16 M355.83%
2001-12-31S$2.44 M-75.59%
2000-12-31S$10.03 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
S$62.71 B 66,295.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$80.81 B 85,466.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$70.22 B 74,246.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$57.61 B 60,902.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
S$29.19 M-69.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA